Skip to content

AIGH Capital Management LLC 13F Holdings · Q2 2026

AIGH Capital Management LLC reported 42 securities worth $1.59B in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: SNDK (21.35%), IWM (20.89%), QQQ (8.93%). Among its top 25 positions this quarter: 13 new, 5 added, 7 trimmed.

RankTickerCompanyValue% PortfolioSharesAction
1SNDKSANDISK CORP$338.8M21.35%149,000Trimmed
2IWMISHARES TR$331.4M20.89%1.1MAdded
3QQQINVESCO QQQ TR$141.8M8.93%192,500New
4MXLMAXLINEAR INC$104.7M6.60%818,000New
5INTCINTEL CORP$87.1M5.49%623,500New
6APPSDIGITAL TURBINE INC$84.5M5.32%6.5MAdded
7SIMOSILICON MOTION TECHNOLOGY CO$48.0M3.03%144,000Trimmed
8CLFDCLEARFIELD INC$40.1M2.53%1.0MNew
9MEIMETHODE ELECTRS INC$31.8M2.01%1.7MNew
10ASYSAMTECH SYS INC$28.9M1.82%1.3MNew
11FENCFENNEC PHARMACEUTICALS INC$26.7M1.68%2.5MAdded
12KYTXKYVERNA THERAPEUTICS INC$24.9M1.57%2.8MAdded
13NYXHNYXOAH S A$24.6M1.55%14.5MNew
14PSNLPERSONALIS INC$23.0M1.45%1.7MTrimmed
15SOPHSOPHIA GENETICS SA$22.8M1.44%4.0MNew
16DDD3D SYS CORP DEL$22.0M1.38%7.3MNew
17VUZIVUZIX CORP$19.6M1.23%6.7MAdded
18ABEOABEONA THERAPEUTICS INC$18.5M1.16%3.0MTrimmed
19ARDXARDELYX INC$16.3M1.03%3.2MNew
20BDSXBIODESIX INC$15.3M0.96%678,328Trimmed
21SPRBSPRUCE BIOSCIENCES INC$13.5M0.85%250,000New
22CSTLCASTLE BIOSCIENCES INC$13.0M0.82%545,101Trimmed
23VNDAVANDA PHARMACEUTICALS INC$12.5M0.79%2.0MTrimmed
24PTHSPELTHOS THERAPEUTICS INC$9.3M0.59%329,098New
25DOMODOMO INC$9.0M0.57%2.9MNew

Source: SEC Form 13F filings · as of 2026-06-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR